Canaccord Reiterates Buy Rating on Niagen Bioscience (NAGE)

July 10, 2026 6:55 AM

Canaccord analyst Susan Anderson reiterated a Buy rating and $10.00 price target on Niagen Bioscience (NASDAQ: NAGE).The analyst commented: "Niagen ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found